Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 17/20 | 0.47 |
| ▸ | ITGAV | P06756 | 17/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | WDR5 | P61964 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7036029 | 0.96 | ITGB3 (0.52) | ITGB3ITGAVITGA2BALDH1A1ALOX15 | |
| SCHEMBL7032795 | 0.90 | ITGB3 (0.48) | ITGB3ITGAVITGA2B | |
| SCHEMBL7038297 | 0.90 | ITGB3 (0.49) | ITGB3ITGAVITGA2BMEN1KMT2A | |
| SCHEMBL7030523 | 0.88 | ALDH1A1 (0.43) | ALDH1A1ALOX15MEN1POLBKMT2A | |
| SCHEMBL7032934 | 0.87 | ITGB3 (0.54) | ITGB3ITGAVITGA2B | |
| SCHEMBL7038916 | 0.86 | ITGB3 (0.54) | ITGB3ITGAVITGA2B | |
| SCHEMBL7036049 | 0.86 | ITGB3 (0.54) | ITGB3ITGAVITGA2B | |
| SCHEMBL7037246 | 0.86 | ITGB3 (0.54) | ITGB3ITGAVITGA2B | |
| SCHEMBL7029571 | 0.86 | ITGB3 (0.49) | ITGB3ITGAVITGA2BWDR5 | |
| SCHEMBL7036086 | 0.86 | ITGB3 (0.55) | ITGB3ITGAVITGA2BMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030186967-A1 | Acylresorcinol derivatives are selective vitronectin receptor inhibitors | AMERICAN HOME PRODUCTS CORPORATION (US) | 2003-10-02 | — | — | US | claimed |
| US-20030186967-A1 | Acylresorcinol derivatives are selective vitronectin receptor inhibitors | AMERICAN HOME PRODUCTS CORPORATION (US) | 2003-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030186967-A1 | Acylresorcinol derivatives are selective vitronectin receptor inhibitors | ASGR1, TEK, APLNR | ITGB3 403/4885ITGAV 289/4885ITGA2B 573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.